The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...
What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
July 10, 2026 • A lot went down this term in the Supreme Court. So, we’re breaking down the landmark SCOTUS decisions that affect Black voters, trans athletes and immigrants. B.A. Parker and Code ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results